4R

Deepverge PLCFRA Deepverge Stock Report

Last reporting period 30 Jun, 2022

Updated —

Last price

Market cap $B

0.002

Micro

Exchange

XFRA - Deutsche Boerse AG

4RG.F Stock Analysis

4R

Uncovered

Deepverge PLC is uncovered by Eyestock quantitative analysis.

Market cap $B

0.002

Dividend yield

Shares outstanding

760.46 B

DeepVerge Plc is a personal health company, which engages in the development and commercialization of technology and products for the human integumentary system. The company is headquartered in Malahide, Dublin and currently employs 73 full-time employees. The company went IPO on 2017-04-05. The firm provides core skin and human testing technology. The firm is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. The company allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.

View Section: Eyestock Rating